Alcohol-induced hepatitis: Clinical sciences

Last updated: June 19, 2023

Alcohol-induced hepatitis: Clinical sciences

Block 2

Block 2

Pentose phosphate pathway
Diabetes mellitus
Disorders of carbohydrate metabolism: Pathology review
Amino acid metabolism
Disorders of amino acid metabolism: Pathology review
Dyslipidemias: Pathology review
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Diabetes mellitus (Type 2): Clinical sciences
Fatty acid synthesis
Wernicke-Korsakoff syndrome
Alcohol-induced hepatitis: Clinical sciences
Diabetes mellitus: Clinical
Diabetes mellitus (Type 1): Clinical sciences
Fetal alcohol syndrome
Diabetes mellitus: Pathology review
Alcohol use disorder
Alcohol-associated liver disease
Enterococcus
Staphylococcus epidermidis
Mycobacterium tuberculosis (Tuberculosis)
Neisseria gonorrhoeae
Corynebacterium diphtheriae (Diphtheria)
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Vitamin D
Klebsiella pneumoniae
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Streptococcus viridans
Clostridium perfringens
Chlamydia trachomatis
Staphylococcus saprophyticus
Staphylococcus aureus
Mycobacterium leprae
Clostridium botulinum (Botulism)
Bacillus anthracis (Anthrax)
Actinomyces israelii
Clostridium tetani (Tetanus)
Streptococcus agalactiae (Group B Strep)
Bacillus cereus (Food poisoning)
Listeria monocytogenes
Pseudomonas aeruginosa
Nocardia
Haemophilus influenzae
Neisseria meningitidis
Treponema pallidum (Syphilis)
Human papillomavirus
Herpes simplex virus
Neuraminidase inhibitors
Human herpesvirus 6 (Roseola)
Borrelia burgdorferi (Lyme disease)
Adenovirus
Yersinia pestis (Plague)
Rhinovirus
Rubella virus
Influenza virus
Mumps virus
Measles virus
Human herpesvirus 8 (Kaposi sarcoma)
Herpesvirus medications
Plasmodium species (Malaria)
Coxiella burnetii (Q fever)
Ehrlichia and Anaplasma
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Anthelmintic medications
Antimalarials
Trypanosoma cruzi (Chagas disease)
Francisella tularensis (Tularemia)
Candida
Anti-mite and louse medications
Miscellaneous antifungal medications
Azoles
Cytokines
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Hyper IgM syndrome
Leukocyte adhesion deficiency
Chronic granulomatous disease
X-linked agammaglobulinemia
Wound healing
Complement deficiency
Inflammation
Pulmonary corticosteroids and mast cell inhibitors
Selective immunoglobulin A deficiency
Necrosis and apoptosis
Ischemia
Wiskott-Aldrich syndrome
Immunodeficiencies: Clinical
Non-corticosteroid immunosuppressants and immunotherapies
Intrinsic hemolytic normocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Blood groups and transfusions
Macrocytic anemia: Pathology review
Cytomegalovirus infection after transplant (NORD)
Glucocorticoids
Blood products and transfusion: Clinical
Acute intermittent porphyria
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Aplastic anemia
Sideroblastic anemia
Microcytic anemia: Pathology review
Erythropoietin
Post-transplant lymphoproliferative disorders (NORD)
Platelet disorders: Pathology review
Thrombotic thrombocytopenic purpura
Neonatal jaundice: Clinical
Jaundice: Clinical
Mixed platelet and coagulation disorders: Pathology review
Von Willebrand disease
Immune thrombocytopenia
Hemolytic-uremic syndrome
Extrinsic hemolytic normocytic anemia: Pathology review
Jaundice
Iron deficiency anemia
Anemia: Clinical
Graft-versus-host disease
Iron deficiency anemia: Clinical sciences
Autoimmune hemolytic anemia
Severe chronic neutropenia (NORD)
Anemia of chronic disease: Year of the Zebra
Jaundice: Pathology review
Blood transfusion reactions and transplant rejection: Pathology review
Anemia of chronic disease
Non-hemolytic normocytic anemia: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Protein synthesis inhibitors: Aminoglycosides
Nucleotide metabolism
Adenosine deaminase deficiency
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Gout
Gout and pseudogout: Pathology review
Lesch-Nyhan syndrome
Gout: Clinical sciences
Oncogenes and tumor suppressor genes
Anti-tumor antibiotics
Blood histology
DNA synthesis inhibitors: Metronidazole
Deep vein thrombosis
Disseminated intravascular coagulation
Factor V Leiden
Protein C deficiency
Protein S deficiency
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Antithrombin III deficiency
Heparin-induced thrombocytopenia
Antiphospholipid syndrome
Hemophilia
Hemophilia: Year of the Zebra
Protease inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Hepatitis medications
HIV and AIDS: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Mechanisms of antibiotic resistance
Coagulation disorders: Pathology review
Integrase and entry inhibitors
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Lymphomas: Pathology review
Chronic leukemia
Acute leukemia
Non-Hodgkin lymphoma
Polycythemia vera (NORD)
Myelodysplastic syndromes
Hodgkin lymphoma
Essential thrombocythemia (NORD)
Waldenstrom macroglobulinemia
Multiple myeloma: Clinical sciences
Mastocytosis (NORD)
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Spleen histology
Myelofibrosis (NORD)
Lymphoma: Clinical
Varicella zoster virus
Coxsackievirus
Congenital TORCH infections: Pathology review
Streptococcus pyogenes (Group A Strep)
Lyme disease: Clinical sciences
Cortisol
Hematopoietic medications
Parvovirus B19
HIV (AIDS)
Zika virus

Decision-Making Tree

Transcript

Watch video only

Alcohol-induced hepatitis, or simply alcoholic hepatitis, refers to acute liver inflammation caused by recent excessive alcohol intake, that presents with jaundice and elevated liver enzymes. Prolonged alcohol intake can result in lipid infiltration and increased production of free oxygen species. Over time, this can lead to inflammation and neutrophilic infiltration of hepatocytes that can eventually lead to fibrosis, cirrhosis, and liver failure. As hepatocytes degenerate, they release intracellular enzymes, such as alanine aminotransferase or ALT, aspartate aminotransferase or AST, and gamma glutamyl transferase or GGT.

Now, if you suspect alcohol-Induced hepatitis, first you should perform an ABCDE assessment to determine if the patient is unstable or stable. If your patient is unstable, stabilize their airway, breathing, and circulation. Next, obtain IV access and put your patient on continuous vital sign monitoring, including blood pressure, heart rate, and pulse oximetry.

Ok, now let’s go back to the ABCDE assessment and take a look at stable individuals.

If the patient is stable, proceed with a focused history and physical exam. Ask your patient specifically about their recent alcohol consumption. Your patient may report heavy drinking, consuming 3 or more drinks per day, usually for a minimum of 6 months. If your patient is hesitant to discuss their alcohol use habits, you could use clinical tools, such as the AUDIT and CAGE questionnaires, which can help you identify harmful drinking patterns. Additionally, your patient might report right upper quadrant pain, nausea, and vomiting. In advanced cases, history might also reveal easy bruising and unintended weight loss.

On the other hand, physical exam often reveals jaundice, right upper quadrant tenderness, hepatomegaly, and splenomegaly. In advanced cases you might see ascites, primarily due to portal hypertension, but also asterixis, agitation, and confusion.

At this point, you should suspect alcohol-induced hepatitis, so your next step is to order labs, such as AST, ALT, GGT, as well as total bilirubin and coagulation studies, primarily INR. Lab results that support the diagnosis of alcohol-induced hepatitis include elevations of AST and ALT usually around 2 times the upper limit of normal, and an AST/ALT ratio higher than 1.5 is highly suggestive of alcoholic liver injury, and sometimes the ratio is even higher than 2. Keep in mind that a normal ratio should be lower than 1. Additionally, GGT and total bilirubin are also elevated, as is the INR to a value of 1.5 or more.

Okay, these lab results in combination with your previous history and physical findings strongly support the diagnosis of alcohol-induced hepatitis. However, some patients can also have variable laboratory findings that are not supportive of the diagnosis. In this case, if your clinical suspicion is still high, you should order a transjugular liver biopsy to confirm or rule out the diagnosis of alcohol-induced hepatitis. If the biopsy shows confirmatory findings like macrovesicular steatosis in a centrilobular pattern, this strongly supports the diagnosis of alcohol-induced hepatitis. On the other hand, non-confirmatory findings should lead you to consider an alternative diagnosis.

Sources

  1. "Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases" Hepatology (2020)
  2. "ACG Clinical Guideline: Alcoholic Liver Disease" Am J Gastroenterol (2018)
  3. "A histologic scoring system for prognosis of patients with alcoholic hepatitis" Gastroenterology (2014)
  4. "EASL Clinical Practice Guidelines: Management of alcohol-related liver disease" J Hepatol (2018)
  5. "The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids" Gut (2007)
  6. "Transjugular liver biopsy: What to do and what not to do. " Indian J Radiol Imaging (2008)